OXON’s FREE LIVE ONLINE WEBINAR SERIES ON RWE ‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscapes of Asia and Europe’ Dates: Monthly starting in May 2024 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST OXON’s webinars on healthcare and real world evidence studies OXON commences its free live online webinar…
Read more
OXON’s RWE solutions at the 39th International Conference on PharmacoEpidemiology, ICPE 2023. The Global Home for the Science of Real-World August 23-27, 2023. | Halifax Convention Centre | Halifax, Nova Scotia, Canada OXON will be supporting ICPE 2023 as an exhibitor, presenting its expertise in RWE during this virtual and in-person interactional scientific event as well…
Read more
Nawab Qizilbash will be speaking at the Global Clinical Trial Connect 2023 Conference 10- 11 May 2023 Nawab Qizilbash, Senior Clinical Epidemiologist and Head of OXON will be participating at the Global Clinical Trials Connect 2023 Conference on Wednesday, 10 May at 11:20h BST | 12:20h CEST. Under the title of “The complementary roles of…
Read more
Thanks for your time at the 38th International Conference on PharmacoEpidemiology, ICPE 2022. August 24-28, 2022 | Bella Center Copenhagen | Copenhagen, Denmark At OXON Epidemiology, we would like to thank you for visiting our booth at ICPE 2022 and contributing to our success during the event. Thanks for your interest in our services during the event…
Read more
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
The study, published in Lancet Healthy Longevity, suggests that high levels of cholesterol in middle-age are associated with an increased risk of developing dementia and Alzheimer’s disease. The retrospective cohort study ‘Blood cholesterol and risk of dementia in a retrospective cohort of over 1.8 million people over two decades’, presented at the 35th International Conference…
Read more
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
OXON Epidemiology leads a group of international European academics and clinicians to conduct the ‘RAPID COVID-19’ research programme of hospitalised COVID-19 patients.
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
